Corporate Social Responsibility Research Of N Company

July 15^th 2018,National Medicine Product Administration issued a notice pointing out that Chang Chun Chang Sheng biotechnology co.,ltd.had made false records in the production of human rabies vaccine.The following series of investigation evidence,government publicity,administrative penalty,all do not affect people's line of sight.The case of vaccine fraud once again brought corporate social responsibility back to the public,while the lack of social responsibility of biological enterprises like Chang Chun pushed these pharmaceutical companies to the forefront.Since the reform in China,the domestic pharmaceutical enterprises have been developing vigorously.In addition to the traditional pharmaceutical enterprises,some innovative biopharmaceutical enterprises have also emerged,and they are welcomed by the capital market.In the new situation under the new policy,the pharmaceutical industry is promising.The case of vaccine fraud has sounded the quality alarm bell for every pharmaceutical company,and at the same time,it has also caused profound reflection of the public-the social responsibility of pharmaceutical companies.In nowadays,the people's demand for drugs has changed from"available drugs"to"good drugs and innovative drugs".The CPC central committee and the state council attach great importance to drug safety supervision and control.At present,the awareness of social responsibility of domestic pharmaceutical enterprises is generally not high.In recent years,drug safety problems frequently occur,which endanger the health and safety of the broad masses of the people.The social credibility of pharmaceutical enterprises also decreases with the exposure of a series of negative events.Pharmaceutical enterprises take the initiative to assume social responsibilities,ensure the quality and safety of drugs,and safeguard the life and health of the public,which is the basis of promoting the sustainable development of the whole industry.Pharmaceutical enterprises are a group of enterprises with relative particularity.Under the new policy and new situation,it is particularly important for domestic pharmaceutical companies to better fulfill their social responsibilities.Multinational pharmaceutical companies are relatively mature in fulfilling social responsibilities.As a leading international pharmaceutical company,N company's commitment to social responsibility is to improve human health through responsible corporate operations.Through actively fulfilling its social responsibility,N company gained good social and economic benefits,achieved corporate sustainable development.Based on N company as an example,to stakeholder theory,triple bottom line when it comes to sustainable theory as a foundation,investigate the development of corporate social responsibility of N company,from the perspective of stakeholders and information disclosure,analyzes its social responsibility and evaluation,and the improving suggestions for N corporate social responsibility,at the same time,combined with its advanced experience,put forward measures and Suggestions for domestic pharmaceutical enterprise social responsibility.This paper holds that?1?social responsibility is an important strategy for the development of enterprises.Only by earnestly fulfilling social responsibility can the sustainable development of enterprises be promoted and the sustainable development of economy,society and environment be promoted.?2?as a special industry,it is particularly important for pharmaceutical enterprises to fulfill their social responsibilities.The responsibility for patients is the core social responsibility of pharmaceutical enterprises.Only by maintaining the health and safety of patients can we benefit the society and promote the sound development of public health.?3?through the case analysis of N company,it is an effective way for pharmaceutical companies to fulfill their social responsibility and achieve sustainable development to enhance their awareness of social responsibility,clarify their social responsibility objectives,highlight their industry characteristics,and combine their sustainable development strategies.?4?based on the analysis of the social responsibility of N company,domestic pharmaceutical enterprises were used for reference.At present,in the process of rapid development of China's pharmaceutical industry,the fulfillment of social responsibility is relatively weak.By drawing on the advanced experience of N company,it is conducive to promoting the sound development of the domestic pharmaceutical industry,so that to achieve the sustainable development of the society and make contributions to the cause of human health.